Nested case-control study of the association of circulating levels of serum insulin-like growth factor I and insulin-like growth factor binding protein 3 with breast cancer in young women in Norway

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Lars J VattenSteinar Tretli

Abstract

High circulating levels of insulin-like growth factor (IGF-I) may elevate the risk of breast cancer in premenopausal women, possibly by increasing cell proliferation and reducing apoptosis. We conducted a nested case-control study among 35,105 Norwegian women who participated in a health screening survey, ages 40 to 42 years, and who were subsequently followed for a mean period of 4.3 years. During this period, 325 women were diagnosed with breast cancer; 647 women without breast cancer, matched on age and time of blood sampling, were selected as controls. Serum concentrations of IGF-I and its main binding protein (IGFBP-3) were measured with radioimmunoassay, and logistic regression analysis was used to adjust for relevant covariates. The mean age at blood collection was 41.1 years in both groups, and the mean age at diagnosis for the cases was 45.4 years (range, 40-51 years). The median IGF-I level did not differ between cases (205 ng/mL) and controls (202 ng/mL). When analyzed by categories of serum IGF-I, the relative risk for women in the highest versus the lowest quintile was 1.46 (95% confidence interval, 0.93-2.32; P(trend) = 0.15) after adjusting for serum IGFBP-3, age, and year of blood collection. The exclusion of ca...Continue Reading

References

Jan 29, 1999·Journal of the National Cancer Institute·H YuX Wu
Mar 16, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Eva S SchernhammerSusan E Hankinson
Dec 29, 2005·International Journal of Cancer. Journal International Du Cancer·Dimitrios TrichopoulosAntonia Trichopoulou
May 27, 2006·Endocrine-related Cancer·Andrew G RenehanAnthony Howell

❮ Previous
Next ❯

Citations

May 18, 2010·The Lancet Oncology·UNKNOWN Endogenous Hormones and Breast Cancer Collaborative GroupAndrew W Roddam
Mar 9, 2012·Breast Cancer : Basic and Clinical Research·Roshni RaoDavid Euhus
Feb 26, 2016·Cancer Prevention Research·Ji YongLiMarie E Wood

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Eva S SchernhammerSusan E Hankinson
© 2022 Meta ULC. All rights reserved